Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 211146
Company: ZYDUS PHARMS
Company: ZYDUS PHARMS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VORTIOXETINE HYDROBROMIDE | VORTIOXETINE HYDROBROMIDE | EQ 5MG BASE | TABLET;ORAL | Discontinued | None | No | No |
| VORTIOXETINE HYDROBROMIDE | VORTIOXETINE HYDROBROMIDE | EQ 10MG BASE | TABLET;ORAL | Discontinued | None | No | No |
| VORTIOXETINE HYDROBROMIDE | VORTIOXETINE HYDROBROMIDE | EQ 20MG BASE | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/02/2024 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/211146Orig1s000ltr.pdf |